メインコンテンツに移動

ICI prospects looking bleak

Despite posting a comparatively robust set of Q3 results, the chemicals giant is still handicapped by a £3 billion-plus debt burden. The planned divestment of ICI’s substantial interest in Hunstman International looks under threat, increasing the likelihood of a rating downgrade. To make matters worse, the spectre of litigation hanging over a US subsidiary is undermining investor confidence and contributing to a pessimistic outlook. Bear Stearns

davidmeade-gif
Lack of cashflow and £3.1 billion net debt is not the best backdrop for a chemical company in the current economic environment. Nevertheless ICI managed to deliver an upbeat set of Q3 results last month, which highlighted the benefits of an improved portfolio mix over past years and greater dependence on more stable specialty and consumer businesses. But how safe are the Baa2-/BBB ratings

コンテンツを印刷またはコピーできるのは、有料の購読契約を結んでいるユーザー、または法人購読契約の一員であるユーザーのみです。

これらのオプションやその他の購読特典を利用するには、info@risk.net にお問い合わせいただくか、こちらの購読オプションをご覧ください: http://subscriptions.risk.net/subscribe

現在、このコンテンツをコピーすることはできません。詳しくはinfo@risk.netまでお問い合わせください。

Sorry, our subscription options are not loading right now

Please try again later. Get in touch with our customer services team if this issue persists.

New to Risk.net? View our subscription options

Most read articles loading...

You need to sign in to use this feature. If you don’t have a Risk.net account, please register for a trial.

ログイン
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here